(Q38159986)

30 August 2017

Wnt pathway in osteosarcoma, from oncogenic to therapeutic (English)

1 reference

30 August 2017

Yu Cai

1

1 reference

PubMed ID

24190862

30 August 2017

Tiange Cai

series ordinal

2

1 reference

PubMed ID

24190862

30 August 2017

Yan Chen

series ordinal

3

1 reference

30 August 2017

1 April 2014

1 reference

Journal of Cellular Biochemistry

30 August 2017

1 reference

30 August 2017

115

1 reference

30 August 2017

4

1 reference

30 August 2017

625-631

1 reference

Wnt/beta-catenin signaling

30 August 2017

1 reference

(18)F and (18)FDG PET imaging of osteosarcoma to non-invasively monitor in situ changes in cellular proliferation and bone differentiation upon MYC inactivation

21 January 2018

1 reference

Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow

21 January 2018

1 reference

High bone density due to a mutation in LDL-receptor-related protein 5

21 January 2018

1 reference

Wnt10b induces chemotaxis of osteosarcoma and correlates with reduced survival

21 January 2018

1 reference

Wnt pathway, an essential role in bone regeneration

21 January 2018

1 reference

Regulation of breast cancer-induced bone lesions by β-catenin protein signaling

21 January 2018

1 reference

Beta-catenin signaling plays a disparate role in different phases of fracture repair: implications for therapy to improve bone healing

21 January 2018

1 reference

Regulation of LEF-1/TCF transcription factors by Wnt and other signals

21 January 2018

1 reference

Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling

21 January 2018

1 reference

21 January 2018

1 reference

Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors

21 January 2018

1 reference

Blocking Wnt/LRP5 signaling by a soluble receptor modulates the epithelial to mesenchymal transition and suppresses met and metalloproteinases in osteosarcoma Saos-2 cells

21 January 2018

1 reference

Dishevelled and Wnt signaling: is the nucleus the final frontier?

21 January 2018

1 reference

Heterozygous mutations in the LDL receptor-related protein 5 (LRP5) gene are associated with primary osteoporosis in children.

21 January 2018

1 reference

Cytoplasmic and/or nuclear accumulation of the beta-catenin protein is a frequent event in human osteosarcoma

21 January 2018

1 reference

A monoclonal antibody against Wnt-1 induces apoptosis in human cancer cells

21 January 2018

1 reference

Wnt, osteosarcoma, and future therapy

21 January 2018

1 reference

Expression of LDL receptor-related protein 5 (LRP5) as a novel marker for disease progression in high-grade osteosarcoma

21 January 2018

1 reference

Dickkopf 3 inhibits invasion and motility of Saos-2 osteosarcoma cells by modulating the Wnt-beta-catenin pathway

21 January 2018

1 reference

Cytoplasmic and/or nuclear staining of beta-catenin is associated with lung metastasis

21 January 2018

1 reference

Anti-tumor effects of dihydroartemisinin on human osteosarcoma

21 January 2018

1 reference

Molecular pathogenesis of osteosarcoma.

21 January 2018

1 reference

Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in mice

21 January 2018

1 reference

Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor

21 January 2018

1 reference

Secreted antagonists of the Wnt signalling pathway

21 January 2018

1 reference

Wnt and calcium signaling: beta-catenin-independent pathways

21 January 2018

1 reference

Dkk-3, a secreted wnt antagonist, suppresses tumorigenic potential and pulmonary metastasis in osteosarcoma.

21 January 2018

1 reference

Inhibition of the Wnt-β-catenin and Notch signaling pathways sensitizes osteosarcoma cells to chemotherapy.

21 January 2018

1 reference

The Wnt signaling pathway: implications for therapy in osteosarcoma

21 January 2018

1 reference

Efficacy of Wnt-1 monoclonal antibody in sarcoma cells

21 January 2018

1 reference

Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context

21 January 2018

1 reference

Wnt10b activates the Wnt, notch, and NFκB pathways in U2OS osteosarcoma cells.

21 January 2018

1 reference

Role of GLI2 in the growth of human osteosarcoma.

21 January 2018

1 reference

Convergence of Wnt, beta-catenin, and cadherin pathways

21 January 2018

1 reference

Function and biological roles of the Dickkopf family of Wnt modulators

21 January 2018

1 reference

Wnt inhibitory factor 1 decreases tumorigenesis and metastasis in osteosarcoma

21 January 2018

1 reference

The ins and outs of Wingless signaling.

21 January 2018

1 reference

Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells

21 January 2018

1 reference

The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma

21 January 2018

1 reference

A REIC gene shows down-regulation in human immortalized cells and human tumor-derived cell lines

21 January 2018

1 reference

Wnt/Frizzled signaling in Ewing sarcoma

21 January 2018

1 reference

Wnt signaling, Ca2+, and cyclic GMP: visualizing Frizzled functions

21 January 2018

1 reference

Celecoxib inhibits β-catenin-dependent survival of the human osteosarcoma MG-63 cell line

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JCB.24708

1 reference

30 August 2017

1 reference

PubMed ID

24190862